Panaraian panyakit koronavirus 2019

Panaraian panyakit koronavirus 2019 kawa maminandui virus SARS-CoV-2 wan tamasuk cara-cara nang kawa manggagai kabaradaan virus ngitu, wan jua antibodi nang dikulih gasan mananggapi pajangkitan virus. Panggagaian antibodi (serologi) kawa dipakai gasan diagnusis wan panjanakan garumbung. Tarai antibodi manunjukakan barapa banyak urang nang sudah tajangkit panyakit, tamasuk nang baisi simtom minor atawa jua kada baisi simtom (asimtomatis). Saupama damintu, waktu wan kamanjuran (efektivitas) tanggapan imunisasi COVID-19 masih balum jalas.^[1]

Marga jumlah tarai nang tawatas, maka par Marit 2020 balum ada nagara nang baisi data nang kawa diparcaya gasan jumlah urang nang takana panyakit ngini.^[2] Par 29 April, nagara-nagara baisi data panaraian wastu gasan 1.4% matan jumlah garumbung bubuhannya, wan kadada nagara nang baisi jumlah cuntuh (sampel) labih matan 14% jumlah garumbungnya.^[3] Tadapat bamamacam jumlah panaraian nng digawi matan nagara ka nagara.^[4] Hal ngini maujaki kaduan jumlah kmatian marga panyakit ngini, nang mungkin labih matan nang dikikiraakan, marga bias pacacahan.^[5]^[6]^[7]

Jujuhutan

^ Abbasi, Jennifer (17 April 2020). "The Promise and Peril of Antibody Testing for COVID-19". JAMA. JAMA Network. doi:10.1001/jama.2020.6170  . PMID 32301958. Diakses tanggal 20 April 2020.
^ Ioannidis, John P.A. (17 March 2020). "A fiasco in the making? As the coronavirus pandemic takes hold, we are making decisions without reliable data". STAT. Diakses tanggal 22 March 2020.
^ "Total tests for COVID-19 per 1,000 people". Our World in Data. Diakses tanggal 16 April 2020.
^ "Iceland has tested more of its population for coronavirus than anywhere else. Here's what it learned". USA Today. 11 April 2020. Diakses tanggal 16 April 2020.
^ Ward, D. (April 2020) "Sampling Bias: Explaining Wide Variations in COVID-19 Case Fatality Rates". WardEnvironment.
^ Henriques, Martha. "Coronavirus: Why death and mortality rates differ". bbc.com (dalam bahasa Inggris). Diakses tanggal 8 April 2020.
^ Michaels, Jonathan A.; Stevenson, Matt D. (2020). "Explaining national differences in the mortality of Covid-19: Individual patient simulation model to investigate the effects of testing policy and other factors on apparent mortality" (PDF). doi:10.1101/2020.04.02.20050633.

[JAMA_anibody-1] Abbasi, Jennifer (17 April 2020). "The Promise and Peril of Antibody Testing for COVID-19". JAMA. JAMA Network. doi:10.1001/jama.2020.6170  . PMID 32301958. Diakses tanggal 20 April 2020.

[2] Ioannidis, John P.A. (17 March 2020). "A fiasco in the making? As the coronavirus pandemic takes hold, we are making decisions without reliable data". STAT. Diakses tanggal 22 March 2020.

[3] "Total tests for COVID-19 per 1,000 people". Our World in Data. Diakses tanggal 16 April 2020.

[4] "Iceland has tested more of its population for coronavirus than anywhere else. Here's what it learned". USA Today. 11 April 2020. Diakses tanggal 16 April 2020.

[:1-5] Ward, D. (April 2020) "Sampling Bias: Explaining Wide Variations in COVID-19 Case Fatality Rates". WardEnvironment.

[6] Henriques, Martha. "Coronavirus: Why death and mortality rates differ". bbc.com (dalam bahasa Inggris). Diakses tanggal 8 April 2020.

[7] Michaels, Jonathan A.; Stevenson, Matt D. (2020). "Explaining national differences in the mortality of Covid-19: Individual patient simulation model to investigate the effects of testing policy and other factors on apparent mortality" (PDF). doi:10.1101/2020.04.02.20050633.

[1]

[2]

[3]

[4]

[5]

[6]

[7]